FDA Inspection 1196124 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on Jan 13, 2023 in Des Moines, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 13, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Des Moines, IA (United States)